This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dr Reddy Laboratories Ltd (RDY)

NYSE: Health Care

Company Balance Sheet
Mar 2014 Mar 2013 Mar 2012 Mar 2011
Assets
Cash and Equivalents 141.22M 94.42M 145.06M 128.33M
Receivables 573.74M 597.07M 509.61M 502.68M
Inventories 400.91M 397.01M 380.44M 359.72M
Other Current Assets 198.62M 144.41M 128.27M 63.15M
Total Current Assets 1.73B 1.58B 1.38B 1.07B
Property, Plant & Equipment, Gross 1.17B 1.08B 1.01B 993.57M
Accumulated Depreciation & Depletion 429.36M 389.89M 355.55M 329.59M
Property, Plant & Equipment, Net 742.32M 695.02M 653.57M 663.98M
Intangibles 188.30M 199.02M 222.56M 292.68M
Other Non-Current Assets 21.74M 21.47M 15.43M 13.19M
Total Non-Current Assets 1.11B 1.04B 973.60M 1.06B
Liabilities & Shareholder Equity
Total Assets 2.84B 2.62B 2.35B 2.13B
Accounts Payable 175.51M 218.02M 186.80M 195.22M
Short Term Debt 401.07M 443.60M 312.08M 409.94M
Other Current Liabilities 326.81M 324.39M 355.49M 151.31M
Total Current Liabilities 903.39M 986.01M 854.37M 918.74M
Long Term Debt 346.57M 232.05M 321.12M 119.08M
Deferred Income Taxes 45.85M 36.45M 22.25M 45.29M
Other Non-Current Liabilities 31.33M 18.56M 21.74M 14.83M
Minority Interest 0.00 -18.38K 0.00 0.00
Total Non-Current Liabilities 423.75M 287.43M 365.12M 179.20M
Total Liabilities 1.33B 1.27B 1.22B 1.10B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.52B 1.34B 1.13B 1.03B
Common Par 14.22M 15.60M 16.67M 18.95M
Additional Paid In Capital 360.15M 389.91M 411.54M 463.30M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 1.09B 823.70M 621.20M 456.76M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 55.91M 114.08M 79.87M 91.17M
Total Capitalization 1.86B 1.58B 1.45B 1.15B
Total Equity 1.52B 1.34B 1.13B 1.03B
Total Liabilities & Stock Equity 2.84B 2.62B 2.35B 2.13B
Total Common Shares Outstanding 170.11M 169.84M 169.56M 169.25M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 170.04M 169.78M 169.47M 169.13M
Diluted Weighted Shares Outstanding 170.70M 170.43M 170.18M 169.97M
Number of Employees 18421 16617 15200 14923
Number of Part-Time Employees 0 0 0 0
RDY News

RDY Dr Reddy Laboratories Ltd

Analysts Ratings for RDY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET RDY ANALYST REPORT

Brokerage Partners

RDY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs